Literature DB >> 4964477

Physicochemical and biological properties of sonically treated Vi antigen.

D G Martin, F G Jarvis, K C Milner.   

Abstract

Electrophoretically purified Vi antigen from Citrobacter freundii 5396/38 was depolymerized by sonic treatment. The treatment caused an 80% reduction in specific viscosity and a reduction in molecular weight from 1.6 x 10(6) to 3.9 x 10(4). The O-acetyl and N-acetyl contents of the antigen and its infrared spectrum remained unchanged. The sonically treated antigen was only 1% as effective as the original antigen in eliciting protection in mice against challenge with Salmonella typhi. Sonically treated antigen also elicited lower antibody titers after single injections in mice and rabbits. No loss in ability to precipitate antibody or to sensitize red blood cells for hemagglutination was observed.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4964477      PMCID: PMC276840          DOI: 10.1128/jb.94.5.1411-1416.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  18 in total

1.  OBSERVATIONS ON MODE OF ACTION OF ENDOTOXIN IN CHICK EMBRYOS.

Authors:  R A FINKELSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

2.  Production of Vi antigen on a chemically defined medium by a coliform bacterium.

Authors:  F G JARVIS; M T MESENKO; K E TIBBS
Journal:  J Bacteriol       Date:  1960-11       Impact factor: 3.490

3.  Electrophoretic purification of the Vi antigen.

Authors:  F G JARVIS; M T MESENKO; J E KYLE
Journal:  J Bacteriol       Date:  1960-11       Impact factor: 3.490

4.  Observations on the pyrogenic response and its application to the bioassay of endotoxin.

Authors:  W R KEENE; H R SILBERMAN; M LANDY
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

5.  Studies on Vi antigen. VIII. Role of acetyl in antigenic activity.

Authors:  M LANDY; A G JOHNSON; M E WEBSTER
Journal:  Am J Hyg       Date:  1961-01

6.  Evidence for an aminohexuronic acid as hydrolytic product of Vi antigen.

Authors:  M E WEBSTER; W R CLARK; M E FREEMAN
Journal:  Arch Biochem Biophys       Date:  1954-05       Impact factor: 4.013

7.  Studies on Vi antigen. II. Purification of Vi antigen from Escherichia coli 5395/38.

Authors:  M E WEBSTER; M LANDY; M E FREEMAN
Journal:  J Immunol       Date:  1952-08       Impact factor: 5.422

8.  Physical and chemical changes of Vi-polysaccharide due to Vi-phage II action.

Authors:  K Taylor
Journal:  Acta Biochim Pol       Date:  1966       Impact factor: 2.149

9.  Enzymatic deacetylation of Vi-polysaccharide by Vi-phage. II.

Authors:  K Taylor
Journal:  Biochem Biophys Res Commun       Date:  1965-09-22       Impact factor: 3.575

10.  Physiochemical properties of the Vi antigen before and after mild alkaline hydrolysis.

Authors:  F G Jarvis; M T Mesenko; D G Martin; T D Perrine
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

View more
  10 in total

1.  Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.

Authors:  G P Andrews; D G Heath; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

2.  Diversity of Vi-related antigens in the microcapsule of Salmonella typhi.

Authors:  B Szewczyk; A Taylor
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

3.  In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidate.

Authors:  Thomas J Griffin; Ann Thanawastien; Robert T Cartee; John J Mekalanos; Kevin P Killeen
Journal:  Hum Vaccin Immunother       Date:  2019-05-28       Impact factor: 3.452

4.  Physiochemical properties of the Vi antigen before and after mild alkaline hydrolysis.

Authors:  F G Jarvis; M T Mesenko; D G Martin; T D Perrine
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

5.  Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi.

Authors:  S C Szu; X R Li; R Schneerson; J H Vickers; D Bryla; J B Robbins
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

6.  Relation between structure and immunologic properties of the Vi capsular polysaccharide.

Authors:  S C Szu; X R Li; A L Stone; J B Robbins
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

7.  Development of a synthetic Vi polysaccharide vaccine for typhoid fever.

Authors:  Yawei Ni; Michael J Springer; Jianhua Guo; Isaac Finger-Baker; James P Wilson; Ronald R Cobb; Debra Turner; Ian Tizard
Journal:  Vaccine       Date:  2017-11-14       Impact factor: 3.641

Review 8.  Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines.

Authors:  Chakkumkal Anish; Michel Beurret; Jan Poolman
Journal:  NPJ Vaccines       Date:  2021-12-10       Impact factor: 7.344

9.  Synthesis and some immunologic properties of an O-acetyl pectin [poly(1-->4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid fever.

Authors:  S C Szu; S Bystricky; M Hinojosa-Ahumada; W Egan; J B Robbins
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.609

10.  Sero-epidemiology and Risk Factor Analysis of Measles Among Children in Pakistan.

Authors:  Muhammad Hidayat Rasool; Ahsan Rafiq; Muhammad Zeeshan Nawaz; Muhammad Shafique; Muhammad Saqalein
Journal:  Pol J Microbiol       Date:  2018-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.